Skip to main content
. 2026 Sep 30;7(5):107. doi: 10.3390/neurosci7050107
AChR Acetylcholine receptor
AChR-Ab+ Acetylcholine receptor antibody-positive
AMSTAR 2 A Measurement Tool to Assess Systematic Reviews 2
C5 Complement component 5
CCA Corrected covered area
FcRn Neonatal Fc receptor
FDA U.S. Food and Drug Administration
gMG Generalized myasthenia gravis
GROOVE Graphical Representation of Overlap for Overviews
IgG Immunoglobulin G
ITC Indirect treatment comparison
JBI Joanna Briggs Institute
LRP4 Low-density lipoprotein receptor-related protein 4
MeSH Medical Subject Headings
MG Myasthenia gravis
MG-ADL Myasthenia Gravis Activities of Daily Living
MGC Myasthenia Gravis Composite
MGFA Myasthenia Gravis Foundation of America
MGFA-PIS Myasthenia Gravis Foundation of America Post-Intervention Status
MG-QOL15r 15-item revised Myasthenia Gravis Quality of Life scale
MuSK Muscle-specific kinase
NMA Network meta-analysis
OSF Open Science Framework
PICO Population, Intervention, Comparator, and Outcome
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
QMG Quantitative Myasthenia Gravis
RCT Randomized controlled trial
RTX Rituximab
SR Systematic review